A comparison between entecavir and tenofovir in chronic hepatitis B in the clinical practice: a single-center experience
Chronic Hepatitis B (CHB) affects 350-400 million of patients worldwide. Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are two nucleoside/nucleotide analogs recommended as first-line treatments in CHB. This retrospective study aimed at comparing effectiveness and renal safety of ETV and TD...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
SEEd
2015-06-01
|
| سلاسل: | Clinical Management Issues |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1191 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|